- Home
- ZJYL vs ANTX Comparison
ZJYL vs ANTX Comparison
Compare ZJYL & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZJYL | ANTX |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.5M | 34.4M |
| IPO Year | 2023 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ZJYL | ANTX |
|---|---|---|
| Price | $0.24 | $1.10 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | ★ 1.7M | 74.1K |
| Earning Date | 08-20-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $22,826,624.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.46 | ★ N/A |
| Revenue Growth | ★ 13.42 | N/A |
| 52 Week Low | $0.22 | $1.01 |
| 52 Week High | $1.42 | $1.66 |
Technical Indicators
Market Signals| Indicator | ZJYL | ANTX |
|---|---|---|
| Relative Strength Index (RSI) | 31.88 | 40.60 |
| Support Level | $0.24 | $1.04 |
| Resistance Level | $0.28 | $1.12 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 9.83 | 33.33 |
Price Performance
Historical ComparisonAbout ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.